BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37263675)

  • 21. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
    Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
    Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hearing and vestibular disturbances in Behçet's syndrome.
    Gemignani G; Berrettini S; Bruschini P; Sellari-Franceschini S; Fusari P; Piragine F; Pasero G; Olivieri I
    Ann Otol Rhinol Laryngol; 1991 Jun; 100(6):459-63. PubMed ID: 2058986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manifestations of Neuro-Behcet's disease. Report of two cases and review of the literature.
    Ho CL; Deruytter MJ
    Clin Neurol Neurosurg; 2005 Jun; 107(4):310-4. PubMed ID: 15885390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
    Arber N; Klein T; Meiner Z; Pras E; Weinberger A
    Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behçet's disease in Western Switzerland: epidemiology and analysis of ocular involvement.
    Ambresin A; Tran T; Spertini F; Herbort C
    Ocul Immunol Inflamm; 2002 Mar; 10(1):53-63. PubMed ID: 12461704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.
    Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.
    Matsui T; Ishida T; Tono T; Yoshida T; Sato S; Hirohata S
    Mod Rheumatol; 2010 Dec; 20(6):621-6. PubMed ID: 20617356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Behçet's disease in a Caucasian with human leukocyte antigen B51 after immigration to Japan.
    Kimura T; Asano Y; Yamamoto M; Sugaya M; Sato S
    J Dermatol; 2011 Jun; 38(6):581-4. PubMed ID: 21914156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.
    Farahangiz S; Sarhadi S; Safari A; Borhani-Haghighi A
    Int J Rheum Dis; 2012 Dec; 15(6):e142-9. PubMed ID: 23253242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-B*5101 in Greek patients with Behçet's disease.
    Koumantaki Y; Stavropoulos C; Spyropoulou M; Messini H; Papademetropoulos M; Giziaki E; Marcomichelakis N; Palimeris G; Kaklamanis P; Kaklamani E
    Hum Immunol; 1998 Apr; 59(4):250-5. PubMed ID: 9568801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behçet's disease in Iraqi patients.
    Al-Rawi ZS; Sharquie KE; Khalifa SJ; Al-Hadithi FM; Munir JJ
    Ann Rheum Dis; 1986 Dec; 45(12):987-90. PubMed ID: 3813669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea.
    Chang HK; Kim JU; Cheon KS; Chung HR; Lee KW; Lee IH
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S31-5. PubMed ID: 11760395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Parenchymal neuro-Behcet's disease. Clinical and paraclinical characteristics, a report of 40 cases].
    Daoudi S; Lounis M; Ait-Kaci-Ahmed M
    Presse Med; 2014 May; 43(5):e119-25. PubMed ID: 24703735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pediatric patient with neuro-Behçet's disease.
    Hatachi S; Nakazawa T; Morinobu A; Kasagi S; Kogata Y; Kageyama G; Kawano S; Koshiba M; Kumagai S
    Mod Rheumatol; 2006; 16(5):321-3. PubMed ID: 17039316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and non-genetic factors affecting the visual outcome of ocular Behcet's disease.
    Kang EH; Park JW; Park C; Yu HG; Lee EB; Park MH; Song YW
    Hum Immunol; 2013 Oct; 74(10):1363-7. PubMed ID: 23831258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.
    Maldini C; Lavalley MP; Cheminant M; de Menthon M; Mahr A
    Rheumatology (Oxford); 2012 May; 51(5):887-900. PubMed ID: 22240504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
    Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
    J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of HLA-B51 subtypes and Behçet's disease in Spain.
    González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
    Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-C genotyping of patient with Behçet's disease in the Japanese population.
    Mizuki N; Ohno S; Ando H; Kimura M; Ishihara M; Miyata S; Nakamura S; Mizuki N; Inoko H
    Hum Immunol; 1996 Sep; 50(1):47-53. PubMed ID: 8872174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
    Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
    Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.